- Papers in database
- 8
- Primary author
- 5 papers
- Years active
- 2010 – 2025
- Health outcomes studied
- 1
Health Outcomes Studied
Papers (8)
- 2025Primary authorEffect of Limosilactobacillus reuteri DSM17938 to prevent antibiotic-associated diarrhea in children: prospective, multi-center, randomized, placebo-controlled clinical trial (PEARL Study).10.1007/s00431-025-06249-8
- 2024Clostridioides difficile Infections: Prevention and Treatment Strategies.10.1007/978-3-031-58572-2_11
- 2022Health Effects of Infant Formula Supplemented with Probiotics or Synbiotics in Infants and Toddlers: Systematic Review with Network Meta-Analysis.10.3390/nu14235175
- 2015Primary authorLactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting.10.1016/j.jped.2014.10.009
- 2015Primary authorSaccharomyces boulardii CNCM I-745 reduces the duration of diarrhoea, length of emergency care and hospital stay in children with acute diarrhoea.10.3920/BM2014.0086
- 2014Primary authorSaccharomyces boulardii CNCM I-745 in different clinical conditions.10.1517/14712598.2014.937419
- 2014Primary authorLactobacillus reuteri DSM 17938 effectively reduces the duration of acute diarrhoea in hospitalised children.10.1111/apa.12617
- 2010Clinical efficacy comparison of Saccharomyces boulardii and yogurt fluid in acute non-bloody diarrhea in children: a randomized, controlled, open label study.10.4269/ajtmh.2010.09-0529